Curapath is pleased to acknowledge the significant progress achieved by Macro Biologics, Inc., whose IND application for Amicidin‑α Surgical Gel has been accepted by the FDA,...
Curapath has partnered with Nacalai Tesque to expand access to its portfolio of next-generation polymers and PEG-free shielding lipids for advanced drug delivery applications in Japan....
Over the past two decades, polymer-based drug delivery systems have evolved from experimental concepts to clinically validated technologies, playing a key role in the development of...
